Expert view: Rahul Ghose of Octanom Tech emphasises the need for tariff clarity and strong Q1 earnings to revitalise the Indian stock market. He discusses potential benefits from an India-US trade deal and identifies top stock picks across various sectors.

Anthem Biosciences' IPO ended on 16 July, with the issue booked over 60 times. Strong demand from qualified institutional buyers drove this. The allotment date is 17 July, and shares are expected to list on 21 July at a premium of 28.07 per cent.

State Bank of India (SBI) on Wednesday said it will raise up to ₹20,000 crore via issue of bonds to domestic investors in current fiscal year.

Wipro's Q1 results are expected to show weak revenue and profit growth, with a possible 2.5% decline in IT services revenue. Management commentary on demand, particularly in Europe, and guidance for Q2FY26 will be crucial for investors.

Central banks are expected to continue increasing gold purchases, viewing it as a viable alternative to the US dollar amid geopolitical tensions. Recent trends show a significant rise in gold prices, with over 1,000 tonnes accumulated annually by central banks.